JP2016108346A5 - - Google Patents

Download PDF

Info

Publication number
JP2016108346A5
JP2016108346A5 JP2016054145A JP2016054145A JP2016108346A5 JP 2016108346 A5 JP2016108346 A5 JP 2016108346A5 JP 2016054145 A JP2016054145 A JP 2016054145A JP 2016054145 A JP2016054145 A JP 2016054145A JP 2016108346 A5 JP2016108346 A5 JP 2016108346A5
Authority
JP
Japan
Prior art keywords
composition according
pimobendan
pharmaceutical composition
carrier matrix
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016054145A
Other languages
English (en)
Japanese (ja)
Other versions
JP6506711B2 (ja
JP2016108346A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016108346A publication Critical patent/JP2016108346A/ja
Publication of JP2016108346A5 publication Critical patent/JP2016108346A5/ja
Application granted granted Critical
Publication of JP6506711B2 publication Critical patent/JP6506711B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016054145A 2013-12-04 2016-03-17 ピモベンダンの改善された医薬組成物 Active JP6506711B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP1300702 2013-12-04
HUP1300702 2013-12-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015554220A Division JP5905999B2 (ja) 2013-12-04 2014-12-01 ピモベンダンの改善された医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019066575A Division JP2019123737A (ja) 2013-12-04 2019-03-29 ピモベンダンの改善された医薬組成物

Publications (3)

Publication Number Publication Date
JP2016108346A JP2016108346A (ja) 2016-06-20
JP2016108346A5 true JP2016108346A5 (enExample) 2018-01-18
JP6506711B2 JP6506711B2 (ja) 2019-04-24

Family

ID=89708176

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015554220A Active JP5905999B2 (ja) 2013-12-04 2014-12-01 ピモベンダンの改善された医薬組成物
JP2016054145A Active JP6506711B2 (ja) 2013-12-04 2016-03-17 ピモベンダンの改善された医薬組成物
JP2019066575A Pending JP2019123737A (ja) 2013-12-04 2019-03-29 ピモベンダンの改善された医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015554220A Active JP5905999B2 (ja) 2013-12-04 2014-12-01 ピモベンダンの改善された医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019066575A Pending JP2019123737A (ja) 2013-12-04 2019-03-29 ピモベンダンの改善された医薬組成物

Country Status (16)

Country Link
US (5) US10172804B2 (enExample)
EP (2) EP3106150B1 (enExample)
JP (3) JP5905999B2 (enExample)
KR (1) KR102308973B1 (enExample)
CN (2) CN105813633B (enExample)
AU (2) AU2014359427B2 (enExample)
BR (2) BR112016011111B1 (enExample)
CA (2) CA2930033C (enExample)
DK (2) DK3106150T3 (enExample)
EA (2) EA034054B1 (enExample)
ES (2) ES2883448T3 (enExample)
HU (2) HUE032347T2 (enExample)
MX (1) MX375936B (enExample)
PL (2) PL3106150T3 (enExample)
WO (1) WO2015082389A1 (enExample)
ZA (1) ZA201602447B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
HUE060093T2 (hu) * 2012-03-15 2023-01-28 Boehringer Ingelheim Vetmedica Gmbh Gyógyszerészeti tablettakészítmény az állatgyógyászati ágazat számára, eljárás annak elõállítására és annak alkalmazása
PL3865120T3 (pl) 2013-07-19 2025-10-13 Boehringer Ingelheim Vetmedica Gmbh Konserwowane eteryfikowane pochodne cyklodekstyrny zawierające ciekłą wodną kompozycję farmaceutyczną
DK3106150T3 (da) 2013-12-04 2021-11-01 Boehringer Ingelheim Vetmedica Gmbh Forbedrede farmaceutiske sammensætninger af pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
EP3257574A1 (en) * 2016-06-15 2017-12-20 Clariant International Ltd Method for producing a particle-shaped material
JP7442540B2 (ja) 2019-02-20 2024-03-04 ゾエティス・サービシーズ・エルエルシー 旨味製剤
AU2020370475A1 (en) * 2019-10-23 2022-05-19 Dechra Veterinary Products, Llc Pimobendan formulation and method of use thereof
RU2762989C1 (ru) * 2020-09-28 2021-12-24 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Способ лечения собак, больных дилатационной кардиомиопатией, осложненной застойной сердечной недостаточностью
WO2022073954A1 (en) 2020-10-08 2022-04-14 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan in the anaesthesia of non-human mammals
CN113804793B (zh) * 2021-09-24 2023-10-31 青岛欧博方医药科技有限公司 匹莫苯丹软咀嚼剂型的杂质检测方法
KR20250119648A (ko) 2022-12-15 2025-08-07 베링거잉겔하임베트메디카게엠베하 비정질 피모벤단 및 하나 이상의 안정화 중합체를 포함하는 고체 분산체
CN121218995A (zh) 2023-05-24 2025-12-26 勃林格殷格翰动物保健有限公司 包含一或多种sglt-2抑制剂及匹莫苯丹和/或替米沙坦的非人类哺乳动物中心脏疾病的组合治疗和/或预防

Family Cites Families (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1045031A (en) 1963-04-30 1966-10-05 Iwao Kawakami Dentifrice
US3574859A (en) 1968-07-05 1971-04-13 Carl M Kosti Process for the treatment of hypertrophied gums
US3822349A (en) 1969-06-02 1974-07-02 C Kosti Vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
CA950833A (en) 1971-02-02 1974-07-09 Carl M. Kosti Composition for the treatment of hypertrophied oral tissue
GB1338169A (en) 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3832460A (en) 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US3839522A (en) 1971-08-02 1974-10-01 Batley Janss Enterprises Process for the manufacture of dog bedding
CH630808A5 (en) 1976-05-08 1982-07-15 Uscio Heinz D Process for aromatising pharmaceutical preparations for veterinary medicine
GB1565966A (en) 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
ES482789A0 (es) 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
DE2841668A1 (de) 1978-09-25 1980-04-10 Bayer Ag Medikiertes tierfutter auf basis lebermehl
US4256743A (en) 1979-02-22 1981-03-17 President And Fellows Of Harvard College Inhibition of bone resorption with H1 -blocking antihistamines
JPS6056143B2 (ja) 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
US4293557A (en) 1979-07-03 1981-10-06 Teikoku Hormone Mfg. Co., Ltd. Antiulcer phenoxypropylamine derivatives
US4375547A (en) 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
IT1209431B (it) 1980-11-28 1989-07-16 Angeli Inst Spa Imidazolilfenil amidine, processi per la loro preparazione e loro impiego farmaceutico, ed intermedi di preparazione.
DE3124090A1 (de) 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4704284A (en) 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
DE3237575A1 (de) 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
GB8313217D0 (en) 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
JPS59222406A (ja) 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4732915A (en) 1983-11-02 1988-03-22 Alza Corporation Process for increasing solubility of drug
DE3346123A1 (de) 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8400863D0 (en) 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
US6407079B1 (en) 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
EP0220044B1 (en) 1985-10-17 1991-01-30 Smith Kline & French Laboratories Limited 4(4-oxo-1,4-dihydropyridin-1-yl)phenyl derivatives
IE63321B1 (en) 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
JPS62223112A (ja) 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
JPH0759496B2 (ja) 1986-03-25 1995-06-28 ロ−ト製薬株式会社 歯周病治療剤
IT1204901B (it) 1986-06-25 1989-03-10 Iscofar Sas Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria
ZA878182B (en) 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US4868182A (en) 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
NL193682C (nl) 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
DE3728244A1 (de) 1987-08-25 1989-03-09 Thomae Gmbh Dr K Neue (-)-benzimidazole, deren herstellung und diese verbindungen enthaltende arzneimittel
EP0306846A3 (de) 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
SE8704436D0 (sv) 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer
US4851226A (en) 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE3804490A1 (de) 1988-02-12 1989-08-24 Heumann Pharma Gmbh & Co Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3805635A1 (de) 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
EP0335545B2 (en) 1988-03-29 1998-09-23 University Of Florida Pharmaceutical formulations for parenteral use
IE62095B1 (en) 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
EP0349657A1 (en) 1988-06-06 1990-01-10 Carl Richard Thornfeldt Manufacture of a medicament for the treatment of teething and colic
GB8824458D0 (en) 1988-10-19 1988-11-23 Orion Yhtymae Oy Substituted pyridazinones
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
JP2916689B2 (ja) 1989-11-16 1999-07-05 株式会社資生堂 化粧料
US5364646A (en) 1990-01-10 1994-11-15 Dr. Karl Thomae Gmbh Oral pharmaceutical forms of pimobendan
DE4001622A1 (de) 1990-01-20 1991-07-25 Thomae Gmbh Dr K Orale arzneimittelformen von pimobendan
DE4001623A1 (de) 1990-01-20 1991-07-25 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines zur behandlung von akuten und chronischen obstruktiven atemwegserkrankungen geeigneten arzneimittels
US5188836A (en) 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
JPH0489428A (ja) 1990-07-30 1992-03-23 Kao Corp 多形核白血球活性化剤
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JPH0570612A (ja) 1991-09-12 1993-03-23 Toyobo Co Ltd 二軸配向ポリエステルフイルム
US5571533A (en) 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
US5472954A (en) 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
CA2190357C (en) 1994-05-20 2007-04-17 Eugene Marie Jozef Jans Chewable flubendazole tablets for companion animals
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
JPH11228302A (ja) 1998-02-18 1999-08-24 Taisho Technos Co Ltd 抗菌防黴組成物
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US20020127205A1 (en) 1998-08-31 2002-09-12 Albert Edge Cells expressing immunoregulatory molecules and uses therefor
JP2002523475A (ja) 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
US20040152664A1 (en) 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
EP1123703B1 (en) 1998-10-23 2004-04-14 Toray Industries, Inc. Immunomodulatory drug composition
FR2790668B1 (fr) 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
MXPA01011800A (es) 1999-05-17 2003-08-19 D B F Granulos que contienen una sustancia vegetal y procedimiento para prepararlos.
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
GB2356346A (en) 1999-11-19 2001-05-23 Mars Uk Ltd Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
CA2400804C (en) 2000-02-04 2009-09-01 Takeda Chemical Industries, Ltd. Stable emulsion compositions of cycloalkene derivatives
EP1260215B1 (en) 2000-03-01 2009-07-29 Eisai R&D Management Co., Ltd. Rapidly disintegrable tablet containing polyvinyl alcohol
JP5026630B2 (ja) 2000-03-31 2012-09-12 小林製薬株式会社 造粒粉体及びその製造方法及び圧縮成形固形物
WO2001097861A2 (en) 2000-06-21 2001-12-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US7744855B2 (en) 2000-06-27 2010-06-29 Vectura Limited Method of making particles for use in a pharmaceutical composition
US6620439B1 (en) 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002049645A1 (en) 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
EP1247456A3 (en) 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
JP2005511475A (ja) 2001-03-02 2005-04-28 ブリストル−マイヤーズ スクイブ カンパニー メラノコルチン受容体のモジュレーターとして有用な化合物及びそれを含む製薬組成物
US20040214797A1 (en) 2001-05-07 2004-10-28 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
ATE481497T1 (de) 2001-08-01 2010-10-15 Univ Utah Am n-terminus trunkierte isoformen von zyklischen phosphodiesterasen pde3a
US6669955B2 (en) 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
EP1443969A2 (en) 2001-10-18 2004-08-11 Decode Genetics EHF Non-inclusion cyclodextrin complexes
BR0307898A (pt) 2002-02-22 2004-12-07 Pharmacia Corp Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
US20030190343A1 (en) 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
DE10209982A1 (de) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
TW200306799A (en) 2002-05-17 2003-12-01 Novartis Ag Combination of organic compounds
JP2005529927A (ja) 2002-05-23 2005-10-06 ファイザー インコーポレイテッド 新規な組み合わせ
SI21223A (sl) 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
DE10228049A1 (de) 2002-06-24 2004-01-15 Merck Patent Gmbh Flüssige Zubereitung enthaltend Oligopeptide
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
WO2004033444A1 (en) 2002-10-07 2004-04-22 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
AU2003297562A1 (en) 2002-11-27 2004-06-23 Artesian Therapeutics, Inc. COMPOUNDS WITH MIXED PDE-INHIBITORY AND Beta-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
JP2006513238A (ja) * 2002-12-19 2006-04-20 ファルマシア・コーポレーション 吸湿性薬物を含む非‐吸湿性製剤
JP2006513222A (ja) 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
US20050085446A1 (en) 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
WO2005035505A2 (en) 2003-09-30 2005-04-21 Artesian Therapeutics, Inc. Compounds with phosphodiesterase inhibiting and calcium channel blocking activities
JP5021318B2 (ja) 2004-01-30 2012-09-05 ファイザー・プロダクツ・インク β−シクロデキストリンを液体投薬形態に用いて多用量製剤を達成するための抗菌性防腐剤
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
JP2005281283A (ja) 2004-03-31 2005-10-13 Akira Matsumori ベンズイミダゾール系薬剤の併用医薬
CA2565159A1 (en) 2004-05-06 2005-12-15 Cydex, Inc. Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
FI20040675A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
KR101352299B1 (ko) * 2004-06-28 2014-02-17 벨로시스 파마슈티컬스 에이/에스 액상 제형용 담체로서의 다공성 정제
NZ534939A (en) 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
US20080090827A1 (en) 2004-11-30 2008-04-17 Artesian Therapeutics, Inc. Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure
WO2006060122A2 (en) 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
CN1702243A (zh) 2005-05-31 2005-11-30 刘坚雄 无壁板框架结构装配组合式房屋建筑及其建造方法
CA2611917A1 (en) 2005-06-13 2006-12-21 Takeda Pharmaceutical Company Limited Injection
EA200800974A1 (ru) * 2005-09-29 2008-10-30 Репрос Терапьютикс Инк. Композиции с улучшенной биодоступностью, содержащие стероидное производное и полигликолизированный глицерид
FR2891459B1 (fr) 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
JP5312034B2 (ja) 2005-11-14 2013-10-09 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 無症候性（潜在性）心不全の治療のためのｐｄｅｉｉｉ阻害剤の使用
ES2276627B1 (es) 2005-12-02 2008-04-16 Bsh Electrodomesticos España, S.A. Tambor de lavadora.
JP4572300B2 (ja) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
CN101365453A (zh) 2006-02-09 2009-02-11 特瓦制药工业有限公司 双嘧达莫缓释制剂及其制备方法
ZA200808114B (en) 2006-03-28 2009-12-30 Javelin Pharmaceuticals Inc Formulations of low dose non-steroidal anti-inflammatory drugs and betacyclodextrin
PE20080697A1 (es) 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
FR2917975B1 (fr) 2007-06-26 2009-10-16 Ceva Sante Animale Sa Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
EP2057982A1 (en) 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
JP5227569B2 (ja) 2007-11-09 2013-07-03 東京インキ株式会社 微粒子乾式コーティング製剤
EP2106786A1 (de) 2008-04-04 2009-10-07 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin
FR2934156B1 (fr) 2008-07-23 2010-09-24 Virbac Medicament appetissant a administration orale sous forme solide
WO2010055119A2 (en) 2008-11-17 2010-05-20 Novartis Ag Pharmaceutical composition comprising pimobendan
HRP20131150T1 (hr) 2008-11-25 2014-01-03 Boehringer Ingelheim Vetmedica Gmbh Pimobendan za uporabu u lijeäśenju hipertrofiäśne kardiomiopatije kod maäśaka
US20100166857A1 (en) 2008-12-30 2010-07-01 Dong Yan Pharmaceutical dosage forms and methods of manufacturing same
GB0912646D0 (en) * 2009-07-21 2009-08-26 Jagotec Ag Improvements in or relating to organic compounds
WO2011022861A1 (zh) * 2009-08-31 2011-03-03 西安力邦医药科技有限责任公司 氟维司群纳米球/微球及其制备方法和用途
CN102647978A (zh) 2009-10-07 2012-08-22 力奇制药公司 包含溶解性差的活性成分和高支化聚合物的药物组合物
NL1037569C2 (en) * 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
EP2338480A1 (en) 2009-12-22 2011-06-29 LEK Pharmaceuticals d.d. Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt
EP2380604A1 (en) 2010-04-19 2011-10-26 InnoRa Gmbh Improved coating formulations for scoring or cutting balloon catheters
CN102805733B (zh) 2011-06-01 2016-03-09 日东电工株式会社 颗粒制剂及其制造方法
JP5813391B2 (ja) * 2011-06-24 2015-11-17 日東電工株式会社 粒子製剤の製造方法
AU2012296925A1 (en) 2011-08-12 2014-02-06 Boehringer Ingelheim Vetmedica Gmbh Taste masked pharmaceutical composition
AU2012101682B4 (en) * 2011-11-20 2013-10-24 Betrola Investments Pty Limited Formulation
ES2656412T3 (es) 2011-12-21 2018-02-27 Elanco Tiergesundheit Ag Nueva combinación
HUE060093T2 (hu) 2012-03-15 2023-01-28 Boehringer Ingelheim Vetmedica Gmbh Gyógyszerészeti tablettakészítmény az állatgyógyászati ágazat számára, eljárás annak elõállítására és annak alkalmazása
GB201207886D0 (en) 2012-05-04 2012-06-20 Jagotec Ag Improvements in or relating to organic compounds
SG10201609364QA (en) 2012-05-18 2017-01-27 Luoda Pharma Pty Ltd Liquid formulation
CN103655502A (zh) 2012-08-31 2014-03-26 瑞普（天津）生物药业有限公司 一种宠物用匹莫苯丹缓释片及其制备方法
FR3002736B1 (fr) 2013-03-04 2015-06-26 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
PL3865120T3 (pl) 2013-07-19 2025-10-13 Boehringer Ingelheim Vetmedica Gmbh Konserwowane eteryfikowane pochodne cyklodekstyrny zawierające ciekłą wodną kompozycję farmaceutyczną
DK3106150T3 (da) 2013-12-04 2021-11-01 Boehringer Ingelheim Vetmedica Gmbh Forbedrede farmaceutiske sammensætninger af pimobendan
PT3389638T (pt) 2015-12-17 2023-11-20 Ceva Sante Animale Composição farmacêutica que compreende pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
AU2020370475A1 (en) 2019-10-23 2022-05-19 Dechra Veterinary Products, Llc Pimobendan formulation and method of use thereof
CN112618505B (zh) 2020-12-30 2022-11-15 南京朗博特动物药业有限公司 一种宠物用含有贝那普利和匹莫苯丹的复方药物组合物及其制备方法

Similar Documents

Publication Publication Date Title
JP2016108346A5 (enExample)
JP5905999B2 (ja) ピモベンダンの改善された医薬組成物
AU2018253545A1 (en) Microcrystalline diketopiperazine compositions and methods
JP2014516080A5 (enExample)
WO2005079755A3 (en) Interleukin-13 antagonist powders, spray-dried particles, and methods
HRP20211606T1 (hr) Oralni farmaceutski pripravci dabigatran-eteksilata
HRP20170014T1 (hr) Farmaceutski pripravak za inhalaciju
RU2014140539A (ru) Агрегированные частицы
WO2006089674A3 (en) Tablets with improved drug substance dispersibility
MX2017004476A (es) Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion.
JP2012509922A5 (enExample)
JP2017122056A (ja) 医薬含有造粒物の製造方法
US8821942B1 (en) Highly compressible, low density ground calcium carbonate granulation and a related method of preparation
JP5619970B2 (ja) 生理活性物質含有粒子の製造方法
WO2009120619A3 (en) Nuclease compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
CN106692093A (zh) 一种琥珀酸美托洛尔缓释片及其制备方法
JP2015151337A (ja) 医薬用組成物の製造方法、医薬用組成物、及び口腔内崩壊錠
GB2575935A8 (en) Method for coating particles
JP2012087147A5 (enExample)
JP6084776B2 (ja) 結晶セルロースを利用した造粒物の製造方法
JPH11246393A5 (enExample)